Latest VYNE reports update at 2024-03-01: 2023 ∙ 2022
  1. Home
  2. Stock quotes
  3. Stock VYNE Therapeutics
VYNE Therapeutics logo

VYNE Therapeutics VYNE

$ 2.65 -5.36%
mail-toReport an Error

Country

 usaUSA

IPO year

 2018

Industry

 -

Stock Exchange

 NASDAQ GLOBAL

CEO

 -

Employees in the company

 -

Shares

 10.3 M

Market Cap[1]

 $ 27.2 M

EBITDA (LTM)

 $ -36.7 M

P/E (LTM)

 -0.36

P/S (LTM)

 21.59

EPS (LTM)

 -9.78

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.